Peptic Ulcer Disease IV: Management
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
Peptic Ulcer Disease II: Pathophysiology
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Mike Paulden1, Nancy Bergstrom2, Susan D Horn3
1Toronto Health Economics and Technology Assessment Collaborative, Toronto, Ontario, Canada.
Reducing repositioning frequency for nursing home residents from 2-hour to 3-hour or 4-hour intervals offers significant economic benefits. This change in pressure ulcer (PrU) prevention strategies can save millions annually in Ontario.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: